Seroepidemiological investigation of COVID-19: A cross-sectional study in Jundiai, São Paulo, Brazil

MJ Batista, CM Lino, CF Tenani, L Zanin… - PLOS Global Public …, 2022 - journals.plos.org
The dramatic increase in the number of COVID-19 cases has been a threat to global health
and a challenge for health systems. Estimating the prevalence of infection in the population …

Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19

P Pan, X Du, Q Zhou, Y Cui, X Deng, C Liu, Z Hu… - Virology Journal, 2022 - Springer
Background Abnormalities of lymphocyte subsets and cytokine profiles have been observed
in most patients with coronavirus disease (COVID-19). Here, we explore the role of …

Immunology and Immunopathology of COVID-19: Precision Medicine and Individualized Treatment Approach are Decisive Factors

T Ghazanfari - 2021 - scholar.archive.org
Currently, we recruited more than a thousand COVID-19 subjects from seven provinces of
Iran. For all patients, we evaluated clinical parameters and several laboratory factors, and …

Dynamic changes in the immune response correlate with disease severity and outcomes during infection with SARS-CoV-2

F Zheng, R Chen, R Yao, Y Huang, X Tan, J Liu… - Infectious Diseases and …, 2021 - Springer
Introduction The coronavirus disease 2019 (COVID-19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread throughout China …

Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status of patients as a major determinant of disease …

M Han, Y Zhang, Z Liu, S Li, M Xu, T He, J Li, Y Gao… - 2020 - papers.ssrn.com
Background: The magnitude of SARS-CoV-2 infection, the dynamic changes of lymphocyte
subsets and cytokines profiles of patients with the novel coronavirus disease (COVID-19) …

Clinical-epidemiology aspect of inpatients with moderate or severe COVID-19 in a Brazilian macroregion: disease and countermeasures

BRO Silva, WF Rodrigues, DGP Abadia… - Frontiers in Cellular …, 2022 - frontiersin.org
COVID-19, also known as coronavirus disease 2019, is an infectious viral disease caused
by SARS-CoV-2, a novel coronavirus. Since its emergence, its epidemiology has been …

Cytokine and chemokine profiles in the sera of COVID-19 patients with different stage of severity

M Bourhis, A Idir, S Machraoui, A Hachimi, Y Elouardi… - Cytokine, 2024 - Elsevier
Introduction COVID-19 is a viral infection that disturbs the host's immune system and causes
an overproduction of cytokines leading to a cytokine storm. The present study aimed to …

Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid‐19 patients

UO Idiz, TT Yurttas, S Degirmencioglu… - Journal of medical …, 2022 - Wiley Online Library
Lymphopenia, T cell subgroup changes, and cytokine level differences are important in the
early diagnosis and treatment of Covid‐19 cases and similar pandemics. We aimed to …

[HTML][HTML] COVID-19: clinical and laboratory manifestations in novel coronavirus infection

AR Xavier, JS Silva, JPCL Almeida… - Jornal Brasileiro de …, 2020 - SciELO Brasil
ABSTRACT COVID-19 is a highly contagious disease caused by the coronavirus of severe
acute respiratory syndrome 2 (SARS-CoV-2). In 2020, due to the outbreak, it was considered …

Clinical characteristics among patients with COVID‑19: A single‑center retrospective study

A Farhana, BA Tantry, NN Shah… - Biomedical …, 2022 - spandidos-publications.com
The aim of the present study was to investigate the clinical features and laboratory
parameters of hospitalized patients with coronavirus disease 2019 (COVID‑19) and assess …